Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |